Literature DB >> 30229827

MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.

L-H Xia1, Q-H Yan, Q-D Sun, Y-P Gao.   

Abstract

OBJECTIVE: The aim of this study was to investigate the expression of micro ribonucleic acid-411-5P (miR-411-5p) in non-small cell lung cancer (NSCLC), and to explore the effect of miR-411-5p on the biological behavior of NSCLC cells as well as the underlying molecular mechanism. PATIENTS AND METHODS: Quantitative Real Time- Polymerase Chain Reaction (qRT-PCR) was used to detect the expression level of miR-411-5p in NSCLC tissues and cells. MiR-411-5p mimics and relevant controls were transfected into NSCLC cells according to the instructions of Lipidosome 2000. Transfected cells were divided into the experimental group and the control group. The transfection efficiency of each group was detected by qRT-PCR. After miR-411-5p overexpression, methyl thiazolyl tetrazolium (MTT) assay, flow cytometry, and transwell assay were used to detect the biological changes of cells in each group. Bioinformatics predicted that pumilio homolog 1 (PUM1) was the target gene of miR-411-5p. Subsequently, the mRNA and protein expression level of PUM1 in each group was detected by qRT-PCR and Western blotting, respectively. Dual-luciferase reporter assay was used to validate the target regulatory relationship between miR-411-5p and PUM1.
RESULTS: The results of qRT-PCR showed that miR-411-5p was relatively lowly expressed in NSCLC tissues and cells. After miR-411-5p overexpression, MTT results revealed that the proliferation of NSCLC cells was decreased. Flow cytometry results indicated that the apoptosis rate of NSCLC cells was increased, and cell cycle was arrested in the G0-G1 phase. Meanwhile, the transwell assay demonstrated that the migration and invasion abilities of NSCLC cells were decreased. Bioinformatics predicted that PUM1 was the target gene of miR-411-5p. After miR-411-4p was overexpressed in NSCLC cells, qRT-PCR and Western blotting showed that both the mRNA and protein expression levels of PUM1 were up-regulated. Moreover, dual-luciferase reporter assay demonstrated that miR-411-5p could significantly inhibit the luciferase activity of wild-type PUM1-3'-untranslated region (3'-UTR). However, it exhibited no effect on the luciferase activity of cells transfected with mutant plasmids.
CONCLUSIONS: MiR-411-5p may be involved in regulating the biological function of NSCLC cells via targeting PUM1. In addition, miR-411-5p may serve as a potential target for the molecular therapy of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30229827     DOI: 10.26355/eurrev_201809_15816

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  Circ_0056618 enhances PRRG4 expression by competitively binding to miR-411-5p to promote the malignant progression of colorectal cancer.

Authors:  Bo Zhang; Wenbin Cao; Yang Liu; Yongkui Zhao; Chunhui Liu; Bingfu Sun
Journal:  Mol Cell Biochem       Date:  2022-08-02       Impact factor: 3.842

2.  LINC00461 Regulates the Recurrence of Large B Cell Lymphoma through the miR-411-5p/BNIP3 Pathway.

Authors:  Shu-Wen Sun; Yan Chen; Hui-Juan Liao; Wei Zhang; Wen-Ming Xu; Guo-Qian He
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-24       Impact factor: 2.650

3.  CircPVT1 Promoted the Progression of Breast Cancer by Regulating MiR-29a-3p-Mediated AGR2-HIF-1α Pathway.

Authors:  Jing Wang; Kuo Huang; Lang Shi; Qingyong Zhang; Shengchu Zhang
Journal:  Cancer Manag Res       Date:  2020-11-12       Impact factor: 3.989

Review 4.  Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy.

Authors:  Meilin Chen; Yijun Liu; Yuqin Yang; Yanbing Qiu; Zhicheng Wang; Xiaoxu Li; Wenling Zhang
Journal:  Genes Dis       Date:  2021-06-03

5.  Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules.

Authors:  Shiqi Zhang; Tao Zeng; Bin Hu; Yu-Hang Zhang; Kaiyan Feng; Lei Chen; Zhibin Niu; Jianhao Li; Tao Huang; Yu-Dong Cai
Journal:  Front Bioeng Biotechnol       Date:  2020-05-26

6.  Pan-cancer analysis of somatic mutations in miRNA genes.

Authors:  Martyna O Urbanek-Trzeciak; Paulina Galka-Marciniak; Paulina M Nawrocka; Ewelina Kowal; Sylwia Szwec; Maciej Giefing; Piotr Kozlowski
Journal:  EBioMedicine       Date:  2020-10-07       Impact factor: 8.143

7.  MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Authors:  Giuseppe Valacchi; Erika Pambianchi; Simona Coco; Alessandra Pulliero; Alberto Izzotti
Journal:  J Pers Med       Date:  2022-01-28

8.  MicroRNA-Mediated Regulation of the Virus Cycle and Pathogenesis in the SARS-CoV-2 Disease.

Authors:  Rosalia Battaglia; Ruben Alonzo; Chiara Pennisi; Angela Caponnetto; Carmen Ferrara; Michele Stella; Cristina Barbagallo; Davide Barbagallo; Marco Ragusa; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

9.  PUM1 is upregulated by DNA methylation to suppress antitumor immunity and results in poor prognosis in pancreatic cancer.

Authors:  Yishi Yang; Xingxing Su; Kaicheng Shen; Chengcheng Zhang; Haisu Dai; Hongbo Ma; Yan Jiang; Ling Shuai; Zhipeng Liu; Jinshan You; Ke Min; Zhiyu Chen
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

10.  PUMILIO proteins promote colorectal cancer growth via suppressing p21.

Authors:  Yuanyuan Gong; Zukai Liu; Yihang Yuan; Zhenzhen Yang; Jiawei Zhang; Qin Lu; Wei Wang; Chao Fang; Haifan Lin; Sanhong Liu
Journal:  Nat Commun       Date:  2022-03-25       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.